We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+251.5%
AUM
$813M
AUM Growth
+$43.5M
Cap. Flow
-$1.72M
Cap. Flow %
-0.21%
Top 10 Hldgs %
20.71%
Holding
251
New
10
Increased
63
Reduced
107
Closed
7

Top Buys

Rank Stock Value
1
ADP icon
Automatic Data Processing
ADP
+$2.9M
2
AL
Air Lease Corp
AL
+$2.05M
3
IQV icon
IQVIA
IQV
+$1.92M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.89M
5
GE icon
GE Aerospace
GE
+$1.74M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$2.64M
2
MIDD icon
Middleby
MIDD
+$2.44M
3
GILD icon
Gilead Sciences
GILD
+$1.58M
4
ROK icon
Rockwell Automation
ROK
+$1.34M
5
AAPL icon
Apple
AAPL
+$1.04M

Sector Composition

Rank Sector Weight
1 Healthcare 17.01%
2 Industrials 14.02%
3 Technology 13.29%
4 Consumer Staples 10.45%
5 Financials 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALLE icon
201
Allegion
ALLE
$14.1B
$382K 0.05%
5,052
– –
IYW icon
202
iShares US Technology ETF
IYW
$25.1B
$378K 0.05%
11,200
– –
HOLX
203
DELISTED
Hologic
HOLX
$371K 0.05%
+8,725
New +$356K
STE icon
204
Steris
STE
$22.7B
$370K 0.05%
5,325
– –
YUM icon
205
Yum! Brands
YUM
$40.3B
$369K 0.05%
5,780
-1,463
-20% -$95.3K
ACN icon
206
Accenture
ACN
$104B
$342K 0.04%
2,856
-220
-7% -$26.3K
GATX icon
207
GATX Corp
GATX
$6.42B
$338K 0.04%
5,550
-16,150
-74% -$951K
UNFI icon
208
United Natural Foods
UNFI
$2.94B
$338K 0.04%
7,825
-7,073
-47% -$318K
VDC icon
209
Vanguard Consumer Staples ETF
VDC
$8B
$338K 0.04%
2,400
+420
+21% +$58.2K
WEC icon
210
WEC Energy
WEC
$35.6B
$332K 0.04%
5,473
– –
UL icon
211
Unilever
UL
$138B
$323K 0.04%
5,822
-1,822
-24% -$92.2K
ACWI icon
212
iShares MSCI ACWI ETF
ACWI
$33.4B
$316K 0.04%
5,000
– –
GSK icon
213
GSK
GSK
$103B
$310K 0.04%
5,883
-476
-7% -$24.1K
JNPR
214
DELISTED
Juniper Networks
JNPR
$306K 0.04%
11,000
– –
SYY icon
215
Sysco
SYY
$39.6B
$306K 0.04%
5,900
– –
AVY icon
216
Avery Dennison
AVY
$13.3B
$298K 0.04%
3,694
– –
TXN icon
217
Texas Instruments
TXN
$259B
$298K 0.04%
3,700
– –
VHT icon
218
Vanguard Health Care ETF
VHT
$18.2B
$295K 0.04%
2,140
+85
+4% +$11.4K
VT icon
219
Vanguard Total World Stock ETF
VT
$79.4B
$293K 0.04%
4,500
– –
FBIN icon
220
Fortune Brands Innovations
FBIN
$6.29B
$289K 0.04%
5,558
– –
VIS icon
221
Vanguard Industrials ETF
VIS
$8.43B
$287K 0.04%
2,320
+90
+4% +$11.1K
VFH icon
222
Vanguard Financials ETF
VFH
$13.7B
$280K 0.03%
+4,630
New +$282K
IGM icon
223
iShares Expanded Tech Sector ETF
IGM
$10.7B
$277K 0.03%
12,000
– –
IVV icon
224
iShares Core S&P 500 ETF
IVV
$900B
$273K 0.03%
1,150
-100
-8% -$23.4K
VNQI icon
225
Vanguard Global ex-US Real Estate ETF
VNQI
$3.53B
$258K 0.03%
+4,845
New +$252K
6 7 8
9
10

Similar funds

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
JFGLC
Johnson Financial Group LLC (Colorado) Denver, Colorado $1.5B AUM 16.09% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
SCM
SG Capital Management Chicago, Illinois $1.51B AUM 49.98% 1-Year Est. Return
FMI
F/M Investments Washington, District of Columbia $1.51B AUM 25.86% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
RCW
Rheos Capital Works Tokyo, Japan $1.5B AUM 47.78% 1-Year Est. Return

Boston Family Office's Q1 2017 Portfolio in Review

As of Q1 2017, Boston Family Office held 251 positions worth $813M, up 5.6% from $770M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Boston Family Office's Q1 2017 filing shows 10 new, 63 increased, 107 reduced and 7 closed positions. Its largest new stake was Teradyne: 22,100 shares worth $687K. The largest sale was Teva Pharmaceuticals, an estimated $2.64M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.

  • Boston Family Office's largest Q1 2017 buy was Teradyne: 22,100 shares worth $687K.
  • Boston Family Office added most to Automatic Data Processing in Q1 2017, an estimated $2.9M increase.
  • Boston Family Office's biggest Q1 2017 reduction was Middleby, cutting an estimated $2.44M.
  • Boston Family Office fully exited Teva Pharmaceuticals in Q1 2017, selling an estimated $2.64M.
  • Boston Family Office's ten largest holdings make up 21% of its $813M portfolio in Q1 2017.
  • Boston Family Office opened 10 new positions and closed 7 in Q1 2017.
  • Boston Family Office's portfolio value rose 5.6% quarter-over-quarter to $813M.

Based on Boston Family Office's 13F filing for Q1 2017, filed 5 May 2017.